We use cookies to make this site work. We'd also like to set optional cookies so we can understand how the site is used and improve it. We will not set optional cookies unless you accept them. You can change your choice at any time from the Cookie settings link in the footer.
Strictly necessary cookies
These cookies are required for the site to work. They store your cookie preferences and keep your session secure. They are exempt from consent under PECR Regulation 6(4) because they are essential to deliver the service you have requested.
Optional cookies
Optional cookies help us understand how the site is used and provide additional features such as analytics, accessibility tools and translation. We will only set them if you accept.
The Relief Trial
Assessing a new relief inhaler for mild Asthma; the overall aim is to determine the clinical effectiveness, cost effectiveness and acceptability, of replacing SABA inhalers with inhalers containing ICS/formoterol in patients with asthma treated with low dose ICS maintenance treatment.
Who can take part?
Patients aged 18 and over with a clinical diagnosis of mild asthma.